Episode 196: Eric Lander's resignation, FDA's about-face, & Pfizer's lucrative pandemic
The Readout Loud
00:00
Cancer Drugs - Is There an Open Door Policy?
The origin story behind these companies thinking pasderkann had an open door policy on chinese cancer drugs? Yes. So we go back to april two thousand 19 megand there was a meeting o the american association chancer research was having their big annual meeting. And they were having a panel session that featured a bunch of chinese pharmoceutical and bitec executives talking about how they could crack the western market with their drugs.
Transcript
Play full episode
